Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Drug legal status

Medical Cannabis Clinicians' Society publishes guidance for prescribers

New guidance has identified conditions for which it says there is strong or weak evidence of efficacy of medical cannabis treatment.

Guidance for the prescription of medical cannabis has been issued by the by the Medical Cannabis Clinicians’ Society (MCCS) and the All-Party Parliamentary Group (APPG) for Medical Cannabis under Prescription.

Published on 20 March 2019, the guidance identifies conditions for which it says there is “conclusive or substantial”, “moderate”, and “limited” evidence of efficacy of medical cannabis treatment — as well as those for which it says there is “no conclusive evidence”.

In the conclusive category, the guidance lists spasticity, pain, chemotherapy-related nausea and vomiting, and epilepsy. It says there is currently no conclusive evidence for efficacy in a range of conditions, including behavioural control in dementia, depression and cancer.

The MCCS recommends that “given that there are few doctors familiar with cannabis medicine, a specialist does not refuse prescription based on their own lack of understanding but seeks to work with an expert cannabis physician”.

To date, there have been no recorded NHS prescriptions for the drug and only a handful of private prescriptions since medical cannabis products were rescheduled in November 2018.

Speaking at a House of Commons Health and Social Care Select Committee evidence session on medical cannabis on 19 March 2019, Mike Barnes, chair of the MCCS, said the guidance was “broader” than the current guidance from the Royal College of Physicians and the British Paediatric Neurology Association.

“This [MCCS guidance] explains a bit more about the background to cannabis generally [and] explains some of the terminology. At a fairly high level, it goes through some of the evidence for the other conditions that may be considered,” Barnes told MPs.

The MCCS describes itself as an “academically independent not-for-profit” group which is “open to any clinician with an interest in cannabis as a medicine”.

The APPG for Medical Cannabis under Prescription defines its purpose as to “secure legislation for access to natural cannabis for medical purposes in the UK under prescription from a medical professional”.

Asked at the evidence session, by Paul Williams, MP for Stockton South, whether there were any competing interests behind the guidance, Barnes said that “we had some support from European Cannabis Holdings (ECH) simply to print [it], but it’s totally independent. I wrote most of it”.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206324

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.